1. Home
  2. MRVI

MRVI

Maravai LifeSciences Holdings Inc.

Logo Maravai LifeSciences Holdings Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-22-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Founded: N/A Country:
United States
United States
Employees: N/A City: SAN DIEGO
Market Cap: 1.0B IPO Year: 2020
Target Price: $11.56 AVG Volume (30 days): 2.8M
Analyst Decision: Buy Number of Analysts: 10
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.90 EPS Growth: N/A
52 Week Low/High: $4.52 - $16.62 Next Earning Date: 05-08-2024
Revenue: $288,945,000 Revenue Growth: -67.28%
Revenue Growth (this year): -3.94% Revenue Growth (next year): 9.93%

Share on Social Networks: